These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

519 related items for PubMed ID: 20590580

  • 21. Fulfilling an unmet need in psoriasis : do biologicals hold the key to improved tolerability?
    Shear NH.
    Drug Saf; 2006; 29(1):49-66. PubMed ID: 16454534
    [Abstract] [Full Text] [Related]

  • 22. TNF alpha inhibitors in the treatment of psoriasis and psoriatic arthritis.
    Tobin AM, Kirby B.
    BioDrugs; 2005; 19(1):47-57. PubMed ID: 15691217
    [Abstract] [Full Text] [Related]

  • 23. Efficacy and safety of etanercept in psoriasis after switching from other treatments: an observational study.
    Mazzotta A, Esposito M, Costanzo A, Chimenti S.
    Am J Clin Dermatol; 2009; 10(5):319-24. PubMed ID: 19658444
    [Abstract] [Full Text] [Related]

  • 24. Annual acquisition and administration cost of biologic response modifiers per patient with rheumatoid arthritis, psoriasis, psoriatic arthritis, or ankylosing spondylitis.
    Bonafede M, Joseph GJ, Princic N, Harrison DJ.
    J Med Econ; 2013 Sep; 16(9):1120-8. PubMed ID: 23808901
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation.
    Woolacott N, Bravo Vergel Y, Hawkins N, Kainth A, Khadjesari Z, Misso K, Light K, Asseburg C, Palmer S, Claxton K, Bruce I, Sculpher M, Riemsma R.
    Health Technol Assess; 2006 Sep; 10(31):iii-iv, xiii-xvi, 1-239. PubMed ID: 16948890
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Biologics and Psoriasis: The Beat Goes On.
    Kim HJ, Lebwohl MG.
    Dermatol Clin; 2019 Jan; 37(1):29-36. PubMed ID: 30466686
    [Abstract] [Full Text] [Related]

  • 30. Secukinumab for treating plaque psoriasis.
    Rothstein B, Gottlieb A.
    Expert Opin Biol Ther; 2016 Jan; 16(1):119-28. PubMed ID: 26577956
    [Abstract] [Full Text] [Related]

  • 31. Use of biological drugs in patients with psoriasis and psoriatic arthritis in Italy: Results from the PSONG survey.
    Potenza MC, Peris K, Berardesca E, Bianchi L, Richetta A, Bernardini N, De Simone C, Teoli M, Zangrilli A, D'epiro S, Orsini D, Narcisi A, Chimenti S, Costanzo A.
    Dermatol Ther; 2018 Jan; 31(1):. PubMed ID: 29215183
    [Abstract] [Full Text] [Related]

  • 32. Use of etanercept in the treatment of psoriasis and psoriatic arthritis.
    Fuchs BS, Hadi S.
    Rev Recent Clin Trials; 2006 Sep; 1(3):259-63. PubMed ID: 18473978
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. A review on golimumab in the treatment of psoriatic arthritis.
    Urdaneta M, Jethwa H, Sultan R, Abraham S.
    Immunotherapy; 2017 Sep; 9(11):871-889. PubMed ID: 28838285
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Etanercept for psoriasis: two case reports.
    Fidalgo A, Baptista J, Rocha Páris F, Caldas Lopes L, Ferreira A.
    Int J Clin Pharmacol Res; 2005 Sep; 25(4):159-63. PubMed ID: 16402631
    [Abstract] [Full Text] [Related]

  • 39. Safety of biologics in psoriasis.
    Kamata M, Tada Y.
    J Dermatol; 2018 Mar; 45(3):279-286. PubMed ID: 29226369
    [Abstract] [Full Text] [Related]

  • 40. The status of biologic therapies in the treatment of moderate to severe psoriasis.
    Menter A.
    Cutis; 2009 Oct; 84(4 Suppl):14-24. PubMed ID: 19916298
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 26.